Back

Transcatheter edge-to-edge mitral valve repair in secondary mitral regurgitation: a meta-analysis of mortality outcomes

17 May 2025 (11:40 - 13:00)
Organised by: Logo
Congress Presentation Part of: ePosters in interventional cardiology (1) Noncoronary Cardiac Intervention HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Doctor Barbara Lage Garcia

Alto Ave Hospital Center, Guimaraes (Portugal)

5 More presentations in this session

Presentation thumbnail
Percutaneous PFO closure for cryptogenic stroke: a single-center experience
Miss I. Conde (Braga, PT)
Abstract Slides Video
Presentation thumbnail
Transcatheter pulmonary valve implantation experience in a Portuguese congenital heart disease center
Doctor A. Pinho (Porto, PT)
Abstract Slides Video
Presentation thumbnail
Left ventricular ejection fraction improvement after transcatheter aortic valve replacement: predictors and prognosis
Doctor M. Paralta De Figueiredo (Evora, PT)
Abstract Slides Video
Presentation thumbnail
Comparative analysis of early stroke risk in transcatheter versus surgical aortic valve replacement in elderly patients: a systematic review and meta-analysis
Mr J. Al Hooti (Dublin, IE)
Abstract Slides Video
Presentation thumbnail
In-hospital outcomes for TAVR under 75: can it hold a candle to SAVR?
Mr D. Inacio Cazeiro (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
ePosters in interventional cardiology (1)

The Event

Event poster

Heart Failure 2025

17 May 2025 11:40 CET
You may be interested in
thumbnail
Congress Presentation
Transcatheter edge-to-edge mitral valve repair: a meta-analysis of hospitalization outcomes in heart failure and secondary mitral regurgitation
thumbnail
Congress Presentation
A meta-analysis on 12-month efficacy outcomes of transcatheter mitral valve repair vs surgery on mitral regurgitation
thumbnail
Congress Presentation
Percutaneous mitral valve repair vs surgery on 12-month mortality and hospitalizations in mitral regurgitation: a meta-analysis of clinical trials and propensity-matched cohorts

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources